|
AGE | Serina Therapeutics, Inc. |
|
|
AGE | Serina Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.04 |
| Leverage | 57.39% |
| Market Cap | $ 421.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -21.2m |
| Margin | 2710.39% |
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of new therapies targeting human aging and degenerative diseases in the United States. The company is headquartered in Alameda, California.